The concept of innovative drugs remains active, and many stocks such as BeiGene have reached new historical highs.

The concept of innovative drugs remains active, with BeiGene, Novartis Huayi, and Jilin Baili Biotechnology all hitting record highs. Kelun Pharmaceutical, Yifang Bioscience, Zejing Pharmaceuticals, Huadong Medicine, and Hengrui Medicine were among the top gainers.